Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08751582dcacff6c6377cf1ff6b66fe6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a7361f51434afc7c7548bbc91c179fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_312631533d53ba52fa172956084a07da http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cda19c11d98cc99f3034a45ecd2691a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-42 |
filingDate |
2011-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_889db920f903c8d0008ec004a59d0bc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208105c6cb203070f067bc41664280c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd38cf3a8d4bca930d8c20dd8dfc625 |
publicationDate |
2011-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011120033-A1 |
titleOfInvention |
Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
abstract |
The present invention provides pharmaceutical compositions for oral administration comprising a therapeutically effective amount of a selective factor Xa inhibitor or a pharmaceutically acceptable salt thereof and an enhancer, wherein the enhancer is a medium chain fatty acid or a salt, ester, ether, or derivative of a medium chain fatty acid and has a carbon chain length of from about 4 to about 20 carbon atoms. The present invention also provides a method for obtaining a reproducible bioavailability of selective factor Xa inhibitor in an object after oral administration comprising orally administering a pharmaceutical composition as described above. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8999383-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2651395-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265384-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2651395-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883203-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883201-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089484-B2 |
priorityDate |
2010-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |